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A middle-aged woman presented with a large mobile mass in her
breast. She had no history of hormonal medication use and no family
history of breast, ovarian, or prostate cancer. The patient complained
of soreness and increase in size of the affected breast. Physical
examination revealed that her breasts were asymmetric with the
affected breast being 2-3 times larger than the other side. Imaging
studies showed a heterogeneous mixed density mass arising in the
breast with extension into the pectoralis major muscle (Figure 1).
An ultrasound-guided core needle biopsy of the mass revealed
large atypical hyperchromatic stromal cells admixed with a mature
adipocytic component, histologically resembling atypical lipomatous
tumor/well-differentiated liposarcoma (ALT/WDL) of soft tissue. The
tumor was positive for MDM2 gene amplification by fluorescence
in situ hybridization (FISH), supporting the diagnosis of a primary
ALT/WDL of the breast.
The patient subsequently underwent simple mastectomy which
showed an approximately 28 cm, predominantly encapsulated mass
consisting of lobulated adipose tissue admixed with bands of fibrous
F IGURE 2 Intraoperative image of the breast mass
Photo courtesy of Dr. Alfred Chang. [Color figure can be viewed at
wileyonlinelibrary.com]
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F IGURE 1 A, Axial T1-weighted image
from a chest MRI showing a large
heterogeneous mass arising in the breast,
involving the pectoralis major and abutting
the pectoralis minor. B, Mediolateral
oblique mammogram showing a
heterogeneous mass containing soft tissue
and fatty components
Received: 15 July 2016 | Accepted: 20 July 2016
DOI: 10.1111/tbj.12916
400 | © 2017 Wiley Periodicals, Inc. wileyonlinelibrary.com/journal/tbj Breast J. 2018;24:400–421.
tissue, minimal fat necrosis and invasion into the underlying pec-
toralis major muscle (Figure 2). Histologically, the tumor consisted of
mature adipose tissue admixed with bands of fibrous tissue contain-
ing characteristic large atypical hyperchromatic stromal cells consis-
tent with a low-grade (FNCLCC grade 1) ALT/WDL.
Immunohistochemical stains for CDK4 and MDM2 showed the
tumor to be strongly, diffusely positive for both markers, further
supporting the diagnosis of primary breast ALT/WDL (Figure 3).
Primary breast sarcomas are exceedingly rare, comprising less
than 0.1% of all malignant breast tumors. The main differential
diagnosis of a primary breast liposarcoma includes malignant phyl-
lodes tumor (MPT) with liposarcomatous differentiation and, in
the case of dedifferentiated liposarcoma (DDL), metaplastic breast
carcinoma (MBC). Currently, all are treated relatively similarly, via
surgical excision and discussion of chemotherapy. However,
emerging targeted therapies may make definitive diagnosis on
small samples more important. These lesions may be difficult to
discern via imaging; however, they can usually be distinguished
pathologically.
The main diagnostic considerations for breast tumors with a sig-
nificant well-differentiated lipomatous component are MPT and pri-
mary ATL/WDL. Limited core biopsy sampling of MPT may only
have sarcomatous overgrowth represented, making the two histolog-
ically indistinguishable. However, Inyang et al (Breast J. 2016.
https://doi.org/10.1111/tbj.12567) and Lyle et al (Histopathology.
2016;68:1040-1045) noted that all 5 and 10 cases, respectively, of
MPT with liposarcomatous stromal overgrowth lacked CDK4 and
MDM2 gene amplification. This is in contrast to ATL/WDLs, which
show positivity for these markers in >90% of cases.
MBCs typically lack liposarcomatous differentiation. However,
spindle cell MBC may be indistinguishable from DDL and both may
have other heterologous sarcomatous elements such as rhabdomyo-,
leiomyo-, osteo-, or chondro-sarcomatous differentiation. Unlike
DDL, the majority of MBC appear to be negative for CDK4 and/or
MDM2. Additionally, MBC variably express epithelial and myoepithe-
lial markers such as cytokeratins 7, 5/6, AE1/AE3, CAM 5.2, 903
and/or MNF 116 and p63 and/or CD 10, respectively. Among these,
p63 appears to be the most sensitive and specific marker for spindle
cell MBC, the main differential consideration for primary breast
DDL.
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F IGURE 3 A, Low power image of the
primary breast liposarcoma (H&E, 2X). B,
High power view showing atypical stromal
cells admixed with adipocytes (H&E, 20X)
and C, corresponding MDM2
immunohistochemical stain highlighting
atypical stromal cells (IHC, 10X) [Color
figure can be viewed at
wileyonlinelibrary.com]
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